Skip to main content
NVDA0.00%AAPL-0.15%GOOGL+0.59%MSFT+0.03%AMZN+0.01%TSM-1.68%SPCX+0.43%AVGO-0.97%META-0.09%TSLA+0.10%SKHY-5.20%MU+0.04%BRK-B+0.06%LLY-0.10%JPM-0.32%WMT-0.09%AMD-3.36%V-0.05%XOM+0.61%ASMLa-1.66%JNJ-0.27%INTC-5.57%MA-0.38%0700.HK-1.94%1398.HK+0.79%ORCL-5.23%ABBV+1.62%BAC-0.18%CSCO-1.82%CVX-0.50%COST-0.02%KO+0.32%LRCX-5.65%CAT-1.29%AP2d-1.55%0005.HK-0.78%AMAT-3.17%UNH-1.22%HSBA.L-1.30%DELL-5.35%PG+0.25%MS-1.22%GE-0.39%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.03%HD-1.53%0939.HK+1.66%GS-0.88%NZDJPY-2.58%AUDJPY-1.80%CHFJPY-1.60%NZDCAD-1.45%NZDUSD-1.44%EURNZD+1.43%GBPNZD+1.39%GBPJPY-1.21%EURJPY-1.20%USDJPY-1.17%CADJPY-1.15%NZDCHF-1.02%USDZAR+0.99%USDSEK+0.98%USDNOK+0.86%AUDNZD+0.81%EURZAR+0.79%EURSEK+0.77%USDTHB+0.72%GBPZAR+0.72%AUDCAD-0.68%EURNOK+0.65%AUDUSD-0.64%AUDDKK-0.63%EURAUD+0.61%CHFSEK+0.59%USDMXN+0.58%GBPAUD+0.58%AUDSGD-0.54%USDPLN+0.49%CHFNOK+0.47%USDCHF+0.44%CADCHF+0.44%NZDSGD-0.42%GBPTRY+0.41%EURCHF+0.40%GBPCHF+0.38%GBPHKD+0.32%USDSGD+0.29%NOKJPY-0.29%GBPMXN-0.28%EURPLN+0.28%SGDJPY+0.27%EURHKD-0.21%USDDKK+0.21%AUDCHF-0.20%USDILS+0.16%NZDMXN-0.15%USDTRY+0.11%USDCNH+0.10%CHFSGD-0.09%EURSGD+0.09%PLNJPY+0.08%EURCNH-0.08%GBPCAD-0.07%EURCAD-0.05%GBPUSD-0.04%USDCOP-0.04%EURUSD-0.04%EURCZK-0.03%EURGBP+0.03%AUDNOK+0.02%GBPSGD+0.02%USDHKD+0.02%USDCAD-0.01%EURDKK+0.01%UKOIL+6.50%USOIL+6.43%XPTUSD-6.23%GAGUSD-5.47%XAGUSD-5.47%HG1-4.75%XAUUSD-1.91%GAUUSD-1.91%XNGUSD+1.68%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.33%ETHUSD-0.18%USDTUSD-0.02%XRPUSD-2.96%SOLUSD-1.53%TRXUSDT+0.12%ZECUSDT-9.23%DOGEUSD-2.23%XMRUSDT-0.01%LINKUSD-1.60%XLMUSD-1.73%BCHUSDT-9.67%LTCUSD-1.56%UNIUSD-1.38%TONUSD+24.88%HBARUSDT-1.83%SUIUSD-3.97%TAOUSDT-5.64%AAVEUSD-2.20%DOTUSDT-1.47%ICPUSDT+1.37%ONDOUSDT-3.29%WLDUSDT-2.91%ATOMUSDT-2.11%ARBUSDT-1.80%JUPUSDT-2.75%INJUSDT-2.57%STXUSDT-4.53%FETUSDT-2.39%TIAUSDT-1.13%PYTHUSDT-1.18%SEIUSDT-6.02%IMXUSDT-3.06%WIFUSDT-4.89%GRTUSDT-3.39%OPUSDT-3.00%POLUSDT-4.79%IOTAUSDT-4.19%AXSUSDT-2.25%FARTCOINUSDT-3.27%EOSUSDT-2.41%DYDXUSDT-1.79%ORDIUSDT-0.96%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA0.00%AAPL-0.15%GOOGL+0.59%MSFT+0.03%AMZN+0.01%TSM-1.68%SPCX+0.43%AVGO-0.97%META-0.09%TSLA+0.10%SKHY-5.20%MU+0.04%BRK-B+0.06%LLY-0.10%JPM-0.32%WMT-0.09%AMD-3.36%V-0.05%XOM+0.61%ASMLa-1.66%JNJ-0.27%INTC-5.57%MA-0.38%0700.HK-1.94%1398.HK+0.79%ORCL-5.23%ABBV+1.62%BAC-0.18%CSCO-1.82%CVX-0.50%COST-0.02%KO+0.32%LRCX-5.65%CAT-1.29%AP2d-1.55%0005.HK-0.78%AMAT-3.17%UNH-1.22%HSBA.L-1.30%DELL-5.35%PG+0.25%MS-1.22%GE-0.39%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.03%HD-1.53%0939.HK+1.66%GS-0.88%NZDJPY-2.58%AUDJPY-1.80%CHFJPY-1.60%NZDCAD-1.45%NZDUSD-1.44%EURNZD+1.43%GBPNZD+1.39%GBPJPY-1.21%EURJPY-1.20%USDJPY-1.17%CADJPY-1.15%NZDCHF-1.02%USDZAR+0.99%USDSEK+0.98%USDNOK+0.86%AUDNZD+0.81%EURZAR+0.79%EURSEK+0.77%USDTHB+0.72%GBPZAR+0.72%AUDCAD-0.68%EURNOK+0.65%AUDUSD-0.64%AUDDKK-0.63%EURAUD+0.61%CHFSEK+0.59%USDMXN+0.58%GBPAUD+0.58%AUDSGD-0.54%USDPLN+0.49%CHFNOK+0.47%USDCHF+0.44%CADCHF+0.44%NZDSGD-0.42%GBPTRY+0.41%EURCHF+0.40%GBPCHF+0.38%GBPHKD+0.32%USDSGD+0.29%NOKJPY-0.29%GBPMXN-0.28%EURPLN+0.28%SGDJPY+0.27%EURHKD-0.21%USDDKK+0.21%AUDCHF-0.20%USDILS+0.16%NZDMXN-0.15%USDTRY+0.11%USDCNH+0.10%CHFSGD-0.09%EURSGD+0.09%PLNJPY+0.08%EURCNH-0.08%GBPCAD-0.07%EURCAD-0.05%GBPUSD-0.04%USDCOP-0.04%EURUSD-0.04%EURCZK-0.03%EURGBP+0.03%AUDNOK+0.02%GBPSGD+0.02%USDHKD+0.02%USDCAD-0.01%EURDKK+0.01%UKOIL+6.50%USOIL+6.43%XPTUSD-6.23%GAGUSD-5.47%XAGUSD-5.47%HG1-4.75%XAUUSD-1.91%GAUUSD-1.91%XNGUSD+1.68%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.33%ETHUSD-0.18%USDTUSD-0.02%XRPUSD-2.96%SOLUSD-1.53%TRXUSDT+0.12%ZECUSDT-9.23%DOGEUSD-2.23%XMRUSDT-0.01%LINKUSD-1.60%XLMUSD-1.73%BCHUSDT-9.67%LTCUSD-1.56%UNIUSD-1.38%TONUSD+24.88%HBARUSDT-1.83%SUIUSD-3.97%TAOUSDT-5.64%AAVEUSD-2.20%DOTUSDT-1.47%ICPUSDT+1.37%ONDOUSDT-3.29%WLDUSDT-2.91%ATOMUSDT-2.11%ARBUSDT-1.80%JUPUSDT-2.75%INJUSDT-2.57%STXUSDT-4.53%FETUSDT-2.39%TIAUSDT-1.13%PYTHUSDT-1.18%SEIUSDT-6.02%IMXUSDT-3.06%WIFUSDT-4.89%GRTUSDT-3.39%OPUSDT-3.00%POLUSDT-4.79%IOTAUSDT-4.19%AXSUSDT-2.25%FARTCOINUSDT-3.27%EOSUSDT-2.41%DYDXUSDT-1.79%ORDIUSDT-0.96%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
CP

Crinetics Pharmaceuticals, Inc. (CRNX)

NASDAQ • Healthcare

$84.95
+$0 (+0.0%)
Market closed

Last close at September 2, 2026 at 20:00 UTC

Open$84.95
Day Range$84.95 - $84.95
Avg. Volume (3M)2.3M
Market Cap$9B
52 Week Range
$32.3$85.01
Next EarningsIn 56 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$25.1M100%
Gross Profitminus cost of goods$24.9M99%

Fundamentals & Financials

Revenue (TTM)
$42.1M
Net Income (TTM)
-$501.6M
EPS (TTM)
-$5.05
ROA (TTM)
-37.95%
Current Ratio
15.57

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+5.8%Q1 2026-$1.29
-0.8%Q2 2026-$1.23
+3.4%Q3 2026-$1.14
Next

Nov 5

in 56 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc. is a NASDAQ-listed biotechnology company developing oral drug candidates for endocrine disorders and related tumors. In qualitative terms, it is a clinical-stage pharmaceutical enterprise rather than a commercial drugmaker, with its work centered on non-peptide therapies that target hormone-signaling pathways.

Name
Crinetics Pharmaceuticals, Inc.
CEO
R. Scott Struthers
Website
www.crinetics.com
Industry
Healthcare
Year Founded
2008
Employees
594

Today's Snapshot

AI-generated

CRNX ended the day flat at 84.95, while its sector was weaker. At the close, CRNX was within 0.1% of its 52-week high of 85.01.

vs S&P 500 Today

Outperforming Market

+0.57%

Updated: September 10, 2026 at 20:33 UTC

CRNX Headlines

Vertex to buy Crinetics for $10 billion

July 6, 2026

3 min read
View All News

Technical Indicators

5 Buy1 Neutral2 Sell
CRNX shows a strong bullish backdrop driven by a very high ADX that signals a powerful trend and a cluster of moving averages stacked well below the current price, indicating broad, multi-timeframe strength. Momentum readings are extreme, with overbought oscillators pointing to strong buying enthusiasm while MACD remains constructive, and on-balance volume is decisively positive, supporting the advance. Volatility is subdued with a low ATR under 0.5%, which favors orderly continuation. Technical takeaway: Strong Buy.
All signals
  • EMA (5 indicators)$56.21 - $84.82
    Buy
  • RSI (14)89.79
    Sell
  • Stochastic %K (14, 3, 3)90.77
    Sell
  • MACD Level (12, 26)2.06
    Neutral

Peers & Related Assets

KYMRKymera Therapeutics, Inc.
$117+1.4%
PRAXPraxis Precision Medicines, Inc.
$338.57-1.9%
IMVTImmunovant, Inc.
$38.1-1.7%
XENEXenon Pharmaceuticals Inc.
$58.8-0.3%
ACADACADIA Pharmaceuticals Inc.
$27.74+0.2%
VKTXViking Therapeutics, Inc.
$32.13-1.7%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.